Temple Lung Center
Playback speed
10 seconds
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease
By
Temple Lung Center
FEATURING
Daniel Salerno
By
Temple Lung Center
FEATURING
Daniel Salerno
178 views
March 7, 2022
Non-tuberculous mycobacteria (NTM), particularly Mycobacterium avium complex (MAC), has become increasingly more prevalent in patients ...
read more ↘ causing pulmonary dysfunction. Daniel Salerno, MD, is the principle investigator for a study designed to determine if clofazimine has anit-mycobacteral activity against MAC. In this video Dr. Salerno explains the study objectives, design as well as patient eligibility criteria, and how to enroll patients who may be candidates.
↖ read less
read more ↘ causing pulmonary dysfunction. Daniel Salerno, MD, is the principle investigator for a study designed to determine if clofazimine has anit-mycobacteral activity against MAC. In this video Dr. Salerno explains the study objectives, design as well as patient eligibility criteria, and how to enroll patients who may be candidates.
↖ read less
Comments 0
Login to view comments.
Click here to Login
Videos